The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment ...

AZ’s triple-combination therapy is already approved under the brand names Breztri Aerosphere and Trixeo Aerosphere to treat ...

Johnson & Johnson (J&J) has received approval from the US Food and Drug Administration for its FcRn blocker Imaavy ...

Medscape Women’s Health is proud to announce its sponsorship of the Society for Women's Health Research (SWHR) 2025 Gala, ...

Connected patches can be used to monitor vital patient parameters in real time, including heart rate, oxygen saturation, ...

The network has introduced a new agency and aligned its medical communications, medical affairs and publications capabilities ...

Novartis has announced that it will be acquiring Regulus Therapeutics in a deal worth $1.7bn, marking a notable boost to the ...

The US Food and Drug Administration (FDA) has approved Abeona Therapeutics’ Zevaskyn (prademagene zamikeracel) for use in ...

Eli Lilly and Creyon Bio have entered into a partnership worth over $1bn to develop RNA-targeted oligonucleotide (oligo) ...

Now more than ever we need to remain focused on the real goals of DE&I – and whether we call it that or not, we surely must ...

AbbVie’s Rinvoq (upadacitinib) has been approved by the US Food and Drug Administration (FDA) to treat adults with giant cell ...

The phase 3 CREST trial has been assessing the subcutaneously-administered drug in combination with standard-of-care Bacillus ...